NORMAX STORY

WEBSITE for Normax Biomed Limited (NRMX)

Normax Extreme Social Impact (ESI) Blog

FACT: EXTREME COST of COVID-19, PATHOGENS & PANDEMIC RISK

WHO. 04 JAN 2023: "XBB.1.5 Most Transmissible Subvariant Yet."

BIOSECURITY: Inevitable Evolution of COVID and New Pathogens

EVERY 20 SECONDS in 2021... Somebody DIED of Tuberculosis (WHO)

Normax IN-THE-NEWS

Normax PRESS ROOM

Normax on TWITTER

Normax SUMMARY

Normax FAQ

Normax at VALIDATE NETWORK

mRNA UCV Consortium by Normax

Normax SOCIAL VALUE (ESG) for Stakeholders and Investors

PURPOSE, CULTURE & VALUES of Normax

LOW-COST mRNA VACCINES for COVID, TB, HIV... by Normax

VACCINE EQUITY. mRNA Vaccines by Normax. Save a Life for $4.00

EDITORIAL. European Pharmaceutical Manufacturer. The time for mRNA vaccine equality across the globe by Peter Jensen

NO PANDEMICS by Normax. PATHOGENS and PANDEMICS. A Deadly Cost and Risk For All.

GOAL 2050 by Normax. End transmission of TB and HIV by 2050.

THE LANCET. 19.8 million deaths from COVID-19 averted during the first year of COVID-19 vaccination

REPORT. COVID-19 Vaccination program in U.S. saved 3.2 million lives and U.S. $1.15 trillion in 2 years

QUICK FACTS. mRNA Vaccine Technology & mRNA in Nature

OPEN ACCESS DATA. Scientific Reference & Review Digest

MARKET REPORTS. Long-Term Market Outlook for mRNA Vaccines and Therapeutics and SARS-CoV-2 Vaccines for Endemic COVID-19

MARKET DATA. Leading mRNA Biomedical & Biotech Companies

MARKET DATA. $110-$130 per Covid Vaccine by Moderna & Pfizer

MARKET DATA. Covid-19 mRNA Vaccines Lead Drug Sales 2021/22

BNTX Q3 2022 EXAMPLE: "€13.4 billion cash and cash equivalents plus total trade receivables of €7.3 billion"

€300,000,000 CAPITAL COMMITMENT secured by Normax

Normax Story FOR INVESTORS in a few minutes...

Linkedin: Peter A. Jensen, CEO & Chairman, Normax Biomed Ltd.